MAPT and Mental deterioration: A recent study combining both Aβ and second-generation tau PET tracers in a group of late-middle-aged healthy participants demonstrated a combined detrimental influence on cognition of both proteins: participants with both elevated Aβ and tau levels experienced three times faster cognitive decline in comparison with those having just one or no elevated biomarkers (Betthauser et al., 2019).